Smith, David C.
University of Michigan Medical School,
United States
2025 Rank: 75309
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 3028 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75309 | 81113 |
| Total Cites | 27125 | 29382 |
| H-index | 61 | 65 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 38 | 41 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1510 | 1636 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 3329 | 3605 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24207 | 25975 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
7.68%
|
|
Smith, David C.
University of Michigan, Ann Arbor,
United States
2024 Rank: 75015
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 3054 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75015 | 81569 |
| Total Cites | 24874 | 26992 |
| H-index | 57 | 59 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 38 | 41 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1445 | 1567 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 3126 | 3395 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 22146 | 23804 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
7.85%
|
|
Smith, David C.
University of Michigan Medical School,
United States
2023 Rank: 71638
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2953 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71638 | 77698 |
| Total Cites | 23154 | 25205 |
| H-index | 56 | 58 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 38 | 41 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1391 | 1514 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 2959 | 3231 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 20543 | 22141 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
8.14%
|
|
Smith, David C.
University of Michigan Medical School,
United States
2022 Rank: 69847
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2907 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69847 | 75981 |
| Total Cites | 20666 | 22565 |
| H-index | 53 | 55 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 38 | 41 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1325 | 1443 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 2760 | 3024 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18272 | 19743 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
8.42%
|
|
Smith, David C.
University of Michigan, Ann Arbor,
United States
2021 Rank: 67485
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2820 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67485 | 74504 |
| Total Cites | 19474 | 21260 |
| H-index | 53 | 54 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 38 | 40 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1281 | 1392 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 2641 | 2890 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17183 | 18579 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
8.40%
|
|
Smith, David C.
University of Michigan, Ann Arbor,
United States
2020 Rank: 69015
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 3021 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69015 | 76473 |
| Total Cites | 16298 | 17913 |
| H-index | 48 | 50 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 38 | 40 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1197 | 1304 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 2385 | 2625 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14206 | 15451 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.16 |
| Self-Citation Percentage |
9.02%
|
|